Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solesence (SLSN) Gains from Investment Securities: 2012-2025

Historic Gains from Investment Securities for Solesence (SLSN) over the last 11 years, with Jun 2025 value amounting to $225,000.

  • Solesence's Gains from Investment Securities was N/A to $225,000 in Q2 2025 from the same period last year, while for Jun 2025 it was $482,000, marking a year-over-year change of. This contributed to the annual value of $3.2 million for FY2024, which is 8.91% down from last year.
  • According to the latest figures from Q2 2025, Solesence's Gains from Investment Securities is $225,000, which was up 125.00% from $100,000 recorded in Q1 2025.
  • Solesence's Gains from Investment Securities' 5-year high stood at $3.2 million during Q1 2023, with a 5-year trough of $11,000 in Q4 2022.
  • Over the past 2 years, Solesence's median Gains from Investment Securities value was $185,500 (recorded in 2023), while the average stood at $924,192.
  • As far as peak fluctuations go, Solesence's Gains from Investment Securities tumbled by 71.05% in 2022, and later skyrocketed by 8,388.87% in 2023.
  • Quarterly analysis of 4 years shows Solesence's Gains from Investment Securities stood at $38,000 in 2021, then crashed by 71.05% to $11,000 in 2022, then spiked by 1,227.27% to $146,000 in 2023, then reached $225,000 in 2025.
  • Its Gains from Investment Securities was $225,000 in Q2 2025, compared to $100,000 in Q1 2025 and $146,000 in Q4 2023.